K-SEPT 1000

K-Sept 1000 - Powerful Debridement

Hard-to-heal wounds represent a major Issue; medically, economically and pshycologically.
In many cases especially diabetic patients, the end solution is to amputate the wounded limb.

Roughly 50% of Diabetic Foot Ulcers become infected and about one in five of these patients will undergo a lower extremity amputation (LEA). In 2016 130,000 Americans were hospitalized for a LEA.

In Israel, around 75% of LEA’s are among diabetic patients and every year there are at least 1,500 LEA’s. The related economic burden is heavy. With effective treatment, many amputations can be prevented.

K-Sept 1000 provides powerful debridement. The patented K-Sept blue solution acts by softening of necrotic tissue, prevention of microbial growth, debris removal and exudate absorption.

K-Sept 1000 is supported by vast clinical experience. It comes in a box of 25 effervescent tablets and registered for “debridement, irrigation, hygiene and cleaning for wounds & skin”. 

K-Sept 1000, with its powerful debridement capability, facilitates the critical shift from Inflammation to Granulation, thus paving the way to wound healing.

Hard-to-Heal Wounds - A Major Issue

By Scope and Severity, by Economic Burden, by Psychosocial Impact

  • In the USA, more than 30M have diabetes (CDC 2020)
  • 25% of US diabetics develop Diabetic Foot Ulcers (CDC)
  • Diabetic Foot Ulcers cost USA $30 billion yearly (Rogers)
  • Pressure ulcers develop in 29% of long Israeli hospitalizations (MOH)
  • Pressure ulcers are “a heavy economic burden” on Israeli healthcare system (MOH)
  • Anxiety and depression are associated with delayed healing in leg ulceration (Cole-King)
  • Amputations are (often) Preventable

  • 50% of Diabetic Foot Ulcers become infected (Lavery)
  • 1 in 5 will undergo a lower extremity amputation (Lavery)
  • 75% of Israeli LEA’s are among diabetics (Research Center, the Knesset)
  • 3 of 1000 Israeli diabetics undergoe an amputation (Res. Center, the Knesset)
  • At least 1,500 LEA’s in Israel, every year (!)
  • Preventable event in 85% of diabetic LEA’s (Pecoraro)
  • K-Sept 1000 - Physical & Use Features

  • Effervescent tablets based on a patented formulation
  • Tablet in 1 L. water provides 1000ppm LAC (Latent Available Chlorine)
  • Blue solution for easy identification
  • Good for use for 48 hours
  • Lightly shake before use
  • pH of solution is 5 to 6, neutral to skin & tissue
  • 25 tablets in a transparent bottle
  • Frequent wetting – essential for facilitating the debridement
  • K-Sept 1000 - Powerful & Proven Debridement

    Effective – Safe – Proven – Easy to Use

    • Backed by vast clinical experience (since 1982)
    • Supported by leading Plastic Surgeons and DFU Specialists
    • Effective for various types of wounds (infected, necrotic // diabetic, neuropathic // burns, amputations // open fractures, crash injuries)
    • Acts by softening necrotic tissue, prevention of microbial growth, debris removal, exudate absorption
    • Facilitates the critical shift from Inflammation to Granulation

    INDICATIONS: debridement, irrigation, hygiene and cleaning solution for wounds & skin (AMAR license 1700405)

    Continuous renewal of solution on the wound (via frequent dressing wetting) is essential for facilitating wound healing.

    References:

    • CDC National Diabetes Statistics Report, 2020.
    • National Diabetes Fact Sheet: General information and national estimates on diabetes in the United States, US Department of Health and Human Services, 2005.
    • Lavery LA, et al. The right to bear legs – how preventing amputations can save billions to the US healthcare system. J Am Podiatr Med Assoc 2008.
    • Pressure Ulcers in Israeli hospitals, Quality Assurance Division, MOH, 2018
    • Cole-King A, Harding KG. Psychological factors and delayed healing in chronic wounds. Psychosom Med 2001.
    • Lavery LA, et al. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003.
    • Data on Diabetes in Israel, Center of Information and Research, the Knesset, 2010.
    • Pecoraro RE, et al. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990.

    K-Sept 1000 - Powerful Debridement

    Skip to content